Literature DB >> 35368347

Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Transplantation: What Are We Waiting For?

Niralee Patel1, Judy Hindi2, Samira S Farouk2.   

Abstract

Entities:  

Keywords:  SGLT2 inhibitors; diabetes; kidney transplant; proteinuria; transplantation

Mesh：

Substances：

Year:  2021        PMID： 35368347      PMCID： PMC8786095          DOI： 10.34067/KID.0000732021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  26 in total

1.  K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

Review 2.  Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.

Authors:  F Zaccardi; D R Webb; Z Z Htike; D Youssef; K Khunti; M J Davies
Journal:  Diabetes Obes Metab       Date:  2016-05-13       Impact factor: 6.577

3.  Use of Canagliflozin in Kidney Transplant Recipients for the Treatment of Type 2 Diabetes: A Case Series.

Authors:  Harindra Rajasekeran; S Joseph Kim; Carl J Cardella; Jeffrey Schiff; Mark Cattral; David Z I Cherney; Sunita K S Singh
Journal:  Diabetes Care       Date:  2017-04-17       Impact factor: 19.112

4.  Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Stephen D Wiviott; Itamar Raz; Marc P Bonaca; Ofri Mosenzon; Eri T Kato; Avivit Cahn; Michael G Silverman; Thomas A Zelniker; Julia F Kuder; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Christian T Ruff; Ingrid A M Gause-Nilsson; Martin Fredriksson; Peter A Johansson; Anna-Maria Langkilde; Marc S Sabatine
Journal:  N Engl J Med       Date:  2018-11-10       Impact factor: 91.245

5.  Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014).

Authors:  Ahmed A Awan; Jingbo Niu; Jenny S Pan; Kevin F Erickson; Sreedhar Mandayam; Wolfgang C Winkelmayer; Sankar D Navaneethan; Venkat Ramanathan
Journal:  Am J Nephrol       Date:  2018-11-23       Impact factor: 3.754

6.  Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Authors:  Bruce Neal; Vlado Perkovic; Kenneth W Mahaffey; Dick de Zeeuw; Greg Fulcher; Ngozi Erondu; Wayne Shaw; Gordon Law; Mehul Desai; David R Matthews
Journal:  N Engl J Med       Date:  2017-06-12       Impact factor: 91.245

7.  Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.

Authors:  Vlado Perkovic; Dick de Zeeuw; Kenneth W Mahaffey; Greg Fulcher; Ngozi Erondu; Wayne Shaw; Terrance D Barrett; Michele Weidner-Wells; Hsiaowei Deng; David R Matthews; Bruce Neal
Journal:  Lancet Diabetes Endocrinol       Date:  2018-06-21       Impact factor: 32.069

8.  SGLT2 Inhibitors and the Risk of Hospitalization for Fournier's Gangrene: A Nested Case-Control Study.

Authors:  Tongtong Wang; Shrita M Patel; Anne Hickman; Xinyue Liu; Philip LStJ Jones; Ira Gantz; Carol E Koro
Journal:  Diabetes Ther       Date:  2020-02-12       Impact factor: 2.945

9.  Early initiation of sodium-glucose linked transporter inhibitors (SGLT-2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients.

Authors:  Chelsey Chenxi Song; Andrew Brown; Ryan Winstead; Idris Yakubu; Moses Demehin; Dhiren Kumar; Gaurav Gupta
Journal:  Endocrinol Diabetes Metab       Date:  2020-09-13

10.  Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States.

Authors:  Kevin C Abbott; Victor J Bernet; Lawrence Y Agodoa; Christina M Yuan
Journal:  BMC Endocr Disord       Date:  2003-03-24       Impact factor: 2.763
View more
  2 in total

Review 1.  Diabetes in Kidney Transplantation.

Authors:  Maria P Martinez Cantarin
Journal:  Adv Chronic Kidney Dis       Date:  2021-11       Impact factor: 3.620

Review 2.  SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Heart Disease: A Literature Review.

Authors:  Abhishek Kansara; Faiza Mubeen; Jawairia Shakil
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.